WALTHAM – Dr. Ginny Sun, a first-year internal medicine resident at Massachusetts General Hospital, is the recipient of the Massachusetts Medical Society’s 2025 Information Technology Award for her project “Detection of immune-related adverse events
using large language models.”
The honor recognizes the development of an information technology tool that helps physicians practice medicine, teach medicine, or pursue clinical research and comes with a $5,000 award.
The award is sponsored by Click Therapeutics, Inc., (“Click”), a leader in Digital Therapeutics™ as prescription medical treatments.
The MMS Information Technology in Medicine awards have been presented annually since 2001 and many winners have seen their projects make indelible marks on science, medicine, and patient care.
Sun grew up in Fairfax, Va., just outside of Washington D.C. She earned her undergraduate degree in Electrical Engineering and Computer Science from the Massachusetts Institute of Technology, where she discovered her passion for the intersection of
health care and technology. This interest led her to pursue a career in medicine at Harvard Medical School. She is excited to continue her clinical training and further her interest in health care innovation. Outside of the hospital, she enjoys
dancing, trying out new recipes, and unwinding with the occasional video game.
Click Therapeutics, Inc., develops, validates, and commercializes software as prescription medical treatments for people with unmet medical needs. As a leading innovator of Digital Therapeutics™, Click delivers accessible, clinically validated, FDA-regulated
prescription treatments to the smartphone in patients’ hands. The company’s treatments prioritize technical and scientific rigor as well as patient-centric design throughout the development process, which results in uniquely engaging experiences
that achieve compelling clinical outcomes for patients seeking new treatment options. Click Therapeutics is continuously expanding and refining its shared platform technologies with novel cognitive, behavioral and neuromodulatory mechanisms of
action and advanced data-driven tools such as artificial intelligence and machine learning. Digital therapeutics under development on Click’s platform address diverse areas of therapeutic need, including indications in psychiatry, neurology, oncology,
immunology, and cardiometabolic diseases. For more information, visit www.clicktherapeutics.com.
